Zelira Therapeutics
(OTCQB:ZLDAF)
$0.8501
Last update: 3:49PM
Day Range- - -52 Wk Range- - 2.53Open / Close- / -Float / Outstanding- / 9.6M
Vol / Avg.- / 1.8KMkt Cap8.1MP/E-50d Avg. Price0.4
Div / Yield-Payout Ratio-Total Float-EPS-

Zelira Therapeutics Stock (OTC:ZLDAF), Quotes and News Summary

Zelira Therapeutics Stock (OTC: ZLDAF)

Day Range- - -52 Wk Range- - 2.53Open / Close- / -Float / Outstanding- / 9.6M
Vol / Avg.- / 1.8KMkt Cap8.1MP/E-50d Avg. Price0.4
Div / Yield-Payout Ratio-Total Float-EPS-
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics Questions & Answers

Q
How do I buy Zelira Therapeutics (ZLDAF) stock?
A

You can purchase shares of Zelira Therapeutics (OTCQB: ZLDAF) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Zelira Therapeutics's (ZLDAF) competitors?
A

There are no as such competitors for Zelira Therapeutics.

Q
What is the target price for Zelira Therapeutics (ZLDAF) stock?
A

There is no analysis for Zelira Therapeutics

Q
Current Stock Price for Zelira Therapeutics (ZLDAF)?
A

The stock price for Zelira Therapeutics (OTCQB: ZLDAF) is $0.8501 last updated September 21, 2022, 7:49 PM UTC.

Q
Does Zelira Therapeutics (ZLDAF) pay a dividend?
A

There are no upcoming dividends for Zelira Therapeutics.

Q
When is Zelira Therapeutics (OTCQB:ZLDAF) reporting earnings?
A

Zelira Therapeutics does not have any upcoming earnings scheduled.

Q
Is Zelira Therapeutics (ZLDAF) going to split?
A

There is no upcoming split for Zelira Therapeutics.

Q
What sector and industry does Zelira Therapeutics (ZLDAF) operate in?
A

Zelira Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.